pancreatic cancer

News

Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay`s MRIdian Linac

08/13/2020

ViewRay, Inc

CLEVELAND, Aug. 13, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Dartmouth-Hitchcock Health in New Hampshire has begun patient treatments with the MRIdian® MRI-Guided Therapy...

CLEVELAND, Aug. 13,...

08/13/2020

IO Learning

Interview

A Novel Dual-Balloon Catheter for the Treatment of Locally Advanced Pancreatic Cancer

06/08/2020

Ripal T. Gandhi, MD, FSIR, FSVM

Ripal T. Gandhi, MD, FSIR, FSVM ...

IO Learning invited Dr Gandhi to discuss his 2020 Society of Interventional Radiology (SIR) abstract, “Overcoming Limitations in the Treatment of Locally Advanced Pancreatic Cancer With Transarterial Microperfusion Utilizing a Novel...

IO Learning invited Dr Gandhi to...

06/08/2020

IO Learning

News

Anti-CEA CAR-T Demonstrates Significant Therapeutic Effect in Pancreatic Cancer Patients With Liver Metastases

11/07/2018

A concentrated dose of anti-CEA CAR-T cells administered precisely at the site of a solid tumor by Pressure-enabled Drug Delivery (PEDD) (TriSalus Life Sciences’) is safe, with encouraging clinical responses, according to the results of a...

A concentrated dose of anti-CEA...

11/07/2018

IO Learning

Blood Test Predicts Treatment Response for NETs

06/27/2016

JCP Editors

A study presented at the 2016 Society of Nuclear Medicine and Molecular Imaging Annual Meeting (June 11-15; San Diego, CA [SNMMI]) has found that a novel investigative blood test could predict how patients with...

A...

06/27/2016

Journal of Clinical Pathways

Research in Review

Pancreatic Cancer Resources Available Online Inaccurate and Difficult to Read

05/13/2016

JCP Editors

Online materials about pancreatic cancer may lack accurate information about alternative therapy and be too complicated to benefit patients with the disease, claims a recent study. The readability and accuracy of...

Online...

05/13/2016

Journal of Clinical Pathways

Research in Review

Chemoradiotherapy Does Not Improve Survival for Patients With Pancreatic Cancer

05/11/2016

JCP Editors

Adding radiation to chemotherapy regimens may not improve overall survival compared with chemotherapy alone in patients with locally advanced pancreatic cancer, according to results from a clinical trial. The trial,...

Adding...

05/11/2016

Journal of Clinical Pathways

TGFŒ≤ Pathway Inhibitor Improves Survival in Patients With Pancreatic Cancer

04/22/2016

JCP Editors

Galunisertib plus gemcitabine may improve overall survival and progression-free survival compared to gemcitabine alone in patients with pancreatic cancer, according to a study presented at the American Association...

...

04/22/2016

Journal of Clinical Pathways

Research in Review

Pancreatic Cancer May Actually Be Four Distinct Diseases

03/03/2016

JCP Editors

Pancreatic cancer may actually present as four separate diseases, according to a recently published study from the United Kingdom. Prognoses for patients with pancreatic cancer are generally poor because a limited...

...

03/03/2016

Journal of Clinical Pathways

Clinical Insights

The CROSSFIRE Study of Irreversible Electroporation for Pancreatic Cancer: Can IRE Improve Survival?

12/27/2015

Laurien Vroomen, MD¹; Hester Scheffer, MD¹; Govindarajan Narayanan, MD²; Martijn Meijerink, MD, PhD¹

From the ¹VU University Medical Center, Amsterdam, the Netherlands, and the ²Miami Miller School of Medicine, Miami, Florida, USA.

Laurien Vroomen, MD1; Hester Scheffer...

Irreversible electroporation (IRE) is a promising new ablation technique to fight pancreatic cancer. Cell death is achieved by delivering high-voltage pulses. The CROSSFIRE trial is an international phase 3, multicenter, randomized controlled...

Irreversible electroporation...

12/27/2015

IO Learning

Interview

Advances and Trends in Interventional Therapies for Pancreatic and Liver Cancer Discussed at Synergy 2015

11/07/2015

By Jennifer FordOn November 6, 2015, the second day of the 2015 Synergy interventional oncology meeting in Miami began with a hands-on ablation workshop. The workshop was packed with attendees, many of whom were residents and fellows who...

By Jennifer FordOn November 6,...

11/07/2015

IO Learning